Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 12
2003 5
2004 5
2005 11
2006 11
2007 18
2008 22
2009 13
2010 18
2011 20
2012 31
2013 35
2014 42
2015 54
2016 68
2017 63
2018 87
2019 108
2020 119
2021 154
2022 154
2023 183
2024 178
2025 59

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,318 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial.
Qin J, Xue L, Hao A, Guo X, Jiang T, Ni Y, Liu S, Chen Y, Jiang H, Zhang C, Kang M, Lin J, Li H, Li C, Tian H, Li L, Fu J, Zhang Y, Ma J, Wang X, Fu M, Yang H, Yang Z, Han Y, Chen L, Tan L, Dai T, Liao Y, Zhang W, Li B, Chen Q, Guo S, Qi Y, Wei L, Li Z, Tian Z, Kang X, Zhang R, Li Y, Wang Z, Chen X, Hou Z, Zheng R, Zhu W, He J, Li Y. Qin J, et al. Among authors: qi y. Nat Med. 2024 Sep;30(9):2549-2557. doi: 10.1038/s41591-024-03064-w. Epub 2024 Jul 2. Nat Med. 2024. PMID: 38956195 Free PMC article. Clinical Trial.
DNA damage response-related immune activation signature predicts the response to immune checkpoint inhibitors: from gastrointestinal cancer analysis to pan-cancer validation.
Yan J, Wang S, Zhang J, Yuan Q, Gao X, Zhang N, Pan Y, Zhang H, Liu K, Yu J, Lu L, Liu H, Gao X, Zhao S, Zhang W, Reyila A, Qi Y, Zhang Q, Cang S, Lu Y, Pan Y, Kong Y, Nie Y. Yan J, et al. Among authors: qi y. Cancer Biol Med. 2023 Dec 29;21(3):252-66. doi: 10.20892/j.issn.2095-3941.2023.0303. Cancer Biol Med. 2023. PMID: 38164720 Free PMC article.
1,318 results